[CAS NO. 2101315-36-8]  Gboxin

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2101315-36-8]

Store
Catalog
SLK-S8828
Brand
Selleck
CAS
2101315-36-8

DESCRIPTION [2101315-36-8]

Overview

MDL-
Molecular Weight392.96
Molecular FormulaC22H33ClN2O2
SMILESC(C(O[C@H]1[C@H]([C@@H](C)C)CC[C@@H](C)C1)=O)[N+]=2C=3C(N(C)C2CC)=CC=CC3.[Cl-]

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.5448 mL12.7239 mL25.4479 mL
5 mM0.5090 mL2.5448 mL5.0896 mL
10 mM0.2545 mL1.2724 mL2.5448 mL
50 mM0.0509 mL0.2545 mL0.5090 mL

Description

Gboxin is an inhibitor of in cancer cells. Gboxin inhibits the activity of . It specifically inhibits the growth of primary mouse and human glioblastoma cells but not that of mouse embryonic fibroblasts or neonatal astrocytes.

Targets

oxidative phosphorylation [1]F0F1 ATP synthase [1]

In vitro

Gboxin rapidly and irreversibly compromises GBM oxygen consumption. Reliant on its positive charge, Gboxin associates with mitochondrial oxidative phosphorylation complexes in a proton gradient dependent manner and inhibits F0F1 ATP synthase activity. Gboxin targets unique features of mitochondrial pH in GBM and other cancer cells, independent of their genetic composition, and exerts its tumor cell specific toxicity in primary culture and in vivo.


Synonyms

1H-Benzimidazolium, 2-ethyl-1-methyl-3-[2-[[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]oxy]-2-oxoethyl]-, chloride (1:1)